Get started
Author

Amy L. Gawad

Early Outpatient Treatment for Covid-19 with Convalescent Plasma
2022 · David J. Sullivan, Kelly A. Gebo, et al. · New England Journal of Medicine · 260
PDF
Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study
2023 · Xianming Zhu, Kelly A Gebo, et al. · The Lancet Microbe · 75
PDF
Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial
2022 · Shmuel Shoham, Evan M Bloch, et al. · Clinical Infectious Diseases · 42
PDF
Enhancing Community Engagement by Schools and Programs of Public Health in the United States
2020 · Mindi B. Levin, Janice V. Bowie, et al. · Annual Review of Public Health · 40
Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma
2021 · David J. Sullivan, Kelly A. Gebo, et al. · medRxiv · 35
PDF
Early antibody treatment, inflammation, and risk of post-COVID conditions
2023 · Kelly A. Gebo, Sonya L. Heath, et al. · mBio · 21
How do I implement an outpatient program for the administration of convalescent plasma for COVID ‐19?
2022 · Evan M. Bloch, Aaron A. R. Tobian, et al. · Transfusion · 19
Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial
2024 · Han-Sol Park, Anna Yin, et al. · JCI Insight · 13
PDF
COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trial
2023 · Feben Habtehyimer, Xianming Zhu, et al. · Microbiology Spectrum · 10
Transfusion reactions associated with COVID ‐19 convalescent plasma in outpatient clinical trials
2023 · Moises A. Huaman, Jay S. Raval, et al. · Transfusion · 9
PDF
Erratum for Gebo et al., “Early antibody treatment, inflammation, and risk of post-COVID conditions”
2023 · Kelly A. Gebo, Sonya L. Heath, et al. · mBio · 5
Selecting trial centers using a standardized, automated site assessment survey instrument (SASI)
2024 · Karen Lane, Shannon Hillery, et al. · Contemporary Clinical Trials · 4
PDF
Early Treatment, Inflammation and Post-COVID Conditions
2023 · Kelly A. Gebo, Sonya L. Heath, et al. · medRxiv · 4
PDF
Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment
2023 · Andrew H. Karaba, Trevor S. Johnston, et al. · mBio · 2
Clinical trial coordination of multifaceted ethical and regulatory oversight entities during the COVID-19 public health emergency
2025 · Amy Gawad, Jessica Mendoza, et al. · Contemporary Clinical Trials
401. Risk of Post-COVID Conditions Correlates with IL-6 Plasma Levels and Is Reduced by Early Antibody Therapy
2023 · Yuriko Fukuta, Kelly Gebo, et al. · Open Forum Infectious Diseases
PDF
Works count: 16
Citation count: 539
H-index: 9
I10-index: 9
Year
Topic
Type